Core Laboratories annual total assets
2021
2022
2023
2024
2025
Core Laboratories Total Assets Growth & History (CLB)
Core Laboratories's total assets was $584.0M for fiscal 2025.
View full Core Laboratories company overviewCore Laboratories annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $584.0M | −$1.1M | −0.19% |
| 2024 | 2024-12-31 | $585.1M | −$1.3M | −0.22% |
| 2023 | 2023-12-31 | $586.4M | $8.0M | +1.39% |
| 2022 | 2022-12-31 | $578.4M | −$2.5M | −0.43% |
| 2021 | 2021-12-31 | $580.9M | — | — |
Core Laboratories quarterly total assets
Q4.22
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $586.8M | −$10.1M | −1.69% |
| Q1 2026 | 2026-03-31 | $587.7M | $1.5M | +0.25% |
| Q4 2025 | 2025-12-31 | $584.0M | −$1.1M | −0.19% |
| Q3 2025 | 2025-09-30 | $591.4M | −$9.1M | −1.52% |
| Q2 2025 | 2025-06-30 | $596.8M | −$964,000 | −0.16% |
| Q1 2025 | 2025-03-31 | $586.2M | −$11.6M | −1.93% |
| Q4 2024 | 2024-12-31 | $585.1M | −$1.3M | −0.22% |
| Q3 2024 | 2024-09-30 | $600.5M | $8.1M | +1.36% |
| Q2 2024 | 2024-06-30 | $597.8M | — | — |
| Q1 2024 | 2024-03-31 | $597.8M | — | — |
| Q4 2023 | 2023-12-31 | $586.4M | $8.0M | +1.39% |
| Q3 2023 | 2023-09-30 | $592.4M | — | — |
| Q4 2022 | 2022-12-31 | $578.4M | — | — |
Core Laboratories total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Core Laboratories's total assets increased from $580.9M to $584.0M, a change of $3.2M. The latest reported quarter, Q2 2026, shows $586.8M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Core Laboratories source filings ↗